Noticias de IONS_US

Mercado

Noticias del mercado

Últimas noticias sobre IONS_US — 420 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: IONS_US ✕ 420 resultados
26/06/2026 IONS_US — Yahoo Finance
IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati
26/06/2026 IONS_US — Investing.com
Ionis Pharmaceuticals EVP research Eric Swayze sells $839k in stock
25/06/2026 IONS_US — Investing.com Canada
Form 144 IONIS PHARMACEUTICALS INC For: 25 June By Investing.com
25/06/2026 IONS_US — bioworld.com
Ionis wins wider Tryngolza approval for hypertriglyceridemia
25/06/2026 IONS_US — Zacks Investment Research
FDA Expands IONS' Tryngolza Label to Treat Severe Hypertriglyceridemia
25/06/2026 IONS_US — Yahoo Finance
FDA Expands IONS' Tryngolza Label to Treat Severe Hypertriglyceridemia
25/06/2026 IONS_US — Seeking Alpha
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction - Slideshow (NASDAQ:IONS) 2026-06-25
25/06/2026 IONS_US — Business Wire
Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S.
25/06/2026 IONS_US — European Biotechnology Magazine
Recordati secures ex-U.S. rights to Ionis’ Alexander disease therapy
25/06/2026 IONS_US — Benzinga
Ionis Climbs As FDA Clears New Therapy To Lower Triglycerides, Pancreatitis Risk
24/06/2026 IONS_US — IONIS
TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
24/06/2026 IONS_US — GuruFocus
Ionis Pharmaceuticals (IONS) Secures FDA Approval for Tryngolza in Severe Hypertriglyceridemia
24/06/2026 IONS_US — Investing.com
Ionis receives FDA approval for severe hypertriglyceridemia drug
24/06/2026 IONS_US — Stock Titan
Ionis hands rare-disease drug zilganersen rights outside the U.S.
24/06/2026 IONS_US — Yahoo Finance
IONS Stock Jumps 4% After-Hours — Goldman Sachs Lifts Price Target On Tryngolza Approval
24/06/2026 IONS_US — Business Wire
TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
16/06/2026 IONS_US — Yahoo Finance
Is lonis Pharmaceuticals, Inc. (IONS) Among the Best Genomics Stocks to Buy According to Analysts?
15/06/2026 IONS_US — Seeking Alpha
Ionis Pharmaceuticals, Inc. (IONS) Presents at National Lipid Association (NLA) 2026 Scientific Sessions - Slideshow
15/06/2026 IONS_US — Stock Titan
Insider plans 8,000-share sale at IONS (NASDAQ: IONS) on 06/15/2026
12/06/2026 IONS_US — Stock Titan
Olezarsen liver fat study data highlighted by Ionis (NASDAQ: IONS)

Página 21 de 21